Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | RORC | P51449 | 4/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.52 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.51 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.51 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.51 |
| ▸ | ATP1A3 | P13637 | 1/20 | 0.51 |
| ▸ | ATP1B2 | P14415 | 1/20 | 0.51 |
| ▸ | ATP1A2 | P50993 | 1/20 | 0.51 |
| ▸ | ATP1B3 | P54709 | 1/20 | 0.51 |
| ▸ | FXYD2 | P54710 | 1/20 | 0.51 |
| ▸ | ATP1A4 | Q13733 | 1/20 | 0.51 |
| ▸ | LSS | P48449 | 4/20 | 0.47 |
| ▸ | NPC1L1 | Q9UHC9 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL337078 | 1.00 | USP2 (0.56) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL5095966 | 1.00 | USP2 (0.56) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL26642363 | 1.00 | USP2 (0.56) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL7512355 | 1.00 | USP2 (0.56) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL7249459 | 0.88 | NR1I2 (0.50) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL4429572 | 0.88 | NR1I2 (0.67) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL4429574 | 0.88 | NR1I2 (0.67) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL31484563 | 0.88 | NR1I2 (0.67) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL29935011 | 0.88 | NR1I2 (0.67) | USP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL7246364 | 0.87 | NR1H4 (0.50) | USP2MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009110612-A1 | NEW COMPOUND DERIVED FROM GERMINATED BROWN RICE, AND AGENT CONTAINING SAID COMPOUND AS AN ACTIVE INGREDIENT FOR PREVENTION OR AMELIORATION OF NEUROPATHY | 株式会社ファンケル (JP) | 2009-09-11 | — | — | WO | claimed |
| US-20010003782-A1 | Meiosis regulating compounds | NOVA NORDISK A/S (DK) | 2001-06-14 | — | — | US | claimed |
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| WO-2009110612-A1 | NEW COMPOUND DERIVED FROM GERMINATED BROWN RICE, AND AGENT CONTAINING SAID COMPOUND AS AN ACTIVE INGREDIENT FOR PREVENTION OR AMELIORATION OF NEUROPATHY | 株式会社ファンケル (JP) | 2009-09-11 | — | — | WO | disclosed |
| EP-1150993-A1 | UNSATURATED CHOLESTANE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS | Schering Aktiengesellschaft (DE) | 2001-11-07 | — | — | EP | disclosed |
| US-20010003782-A1 | Meiosis regulating compounds | NOVA NORDISK A/S (DK) | 2001-06-14 | — | — | US | disclosed |
| WO-2000047604-A1 | UNSATURATED CHOLESTANE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEIOSIS REGULATING MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-08-17 | — | — | WO | disclosed |
| US-5112815-A | Anticholesterol agents | RICHER GEDEON VEGYESZET (HU) | 1992-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010003782-A1 | Meiosis regulating compounds | SREBF2, SREBF1, TRIP13 | USP2 1879/4885MEN1 2167/4885KMT2A 1254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.